These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Disease-causing mutation in α-actinin-4 promotes podocyte detachment through maladaptation to periodic stretch. Feng D; Notbohm J; Benjamin A; He S; Wang M; Ang LH; Bantawa M; Bouzid M; Del Gado E; Krishnan R; Pollak MR Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1517-1522. PubMed ID: 29378953 [TBL] [Abstract][Full Text] [Related]
9. Familial focal segmental glomerulosclerosis (FSGS)-linked α-actinin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptors. Khurana S; Chakraborty S; Lam M; Liu Y; Su YT; Zhao X; Saleem MA; Mathieson PW; Bruggeman LA; Kao HY J Biol Chem; 2012 Apr; 287(15):12027-35. PubMed ID: 22351778 [TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of alpha-actinin 4 upon epidermal growth factor exposure regulates its interaction with actin. Shao H; Wu C; Wells A J Biol Chem; 2010 Jan; 285(4):2591-600. PubMed ID: 19920151 [TBL] [Abstract][Full Text] [Related]
11. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics. Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981 [TBL] [Abstract][Full Text] [Related]
12. α Actinin 4 (ACTN4) Regulates Glucocorticoid Receptor-mediated Transactivation and Transrepression in Podocytes. Zhao X; Khurana S; Charkraborty S; Tian Y; Sedor JR; Bruggman LA; Kao HY J Biol Chem; 2017 Feb; 292(5):1637-1647. PubMed ID: 27998979 [TBL] [Abstract][Full Text] [Related]
13. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury. Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837 [TBL] [Abstract][Full Text] [Related]
14. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling. Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144 [TBL] [Abstract][Full Text] [Related]
15. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. Dai C; Stolz DB; Kiss LP; Monga SP; Holzman LB; Liu Y J Am Soc Nephrol; 2009 Sep; 20(9):1997-2008. PubMed ID: 19628668 [TBL] [Abstract][Full Text] [Related]
17. Activation of RhoA in podocytes induces focal segmental glomerulosclerosis. Zhu L; Jiang R; Aoudjit L; Jones N; Takano T J Am Soc Nephrol; 2011 Sep; 22(9):1621-30. PubMed ID: 21804090 [TBL] [Abstract][Full Text] [Related]
18. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease. Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Importin- α -Mediated Nuclear Localization of Dendrin Attenuates Podocyte Loss and Glomerulosclerosis. Empitu MA; Kikyo M; Shirata N; Yamada H; Makino SI; Kadariswantiningsih IN; Aizawa M; Patrakka J; Nishimori K; Asanuma K J Am Soc Nephrol; 2023 Jul; 34(7):1222-1239. PubMed ID: 37134307 [TBL] [Abstract][Full Text] [Related]
20. Fibrinogen links podocyte injury with Toll-like receptor 4 and is associated with disease activity in FSGS patients. Wang H; Zheng C; Xu X; Zhao Y; Lu Y; Liu Z Nephrology (Carlton); 2018 May; 23(5):418-429. PubMed ID: 28407405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]